Fielmann Aktiengesellschaft (FIE.DE)
EUR 52.5
(5.0%)
EUR 52.5
(5.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 127.64 Million EUR | 23.14% |
| 2022 | 103.65 Million EUR | -24.26% |
| 2021 | 136.85 Million EUR | 17.56% |
| 2020 | 116.4 Million EUR | -32.4% |
| 2019 | 172.2 Million EUR | 1.96% |
| 2018 | 168.88 Million EUR | 0.75% |
| 2017 | 167.62 Million EUR | 0.79% |
| 2016 | 166.3 Million EUR | 0.47% |
| 2015 | 165.53 Million EUR | 5.22% |
| 2014 | 157.31 Million EUR | 13.98% |
| 2013 | 138.02 Million EUR | 9.23% |
| 2012 | 126.36 Million EUR | 3.8% |
| 2011 | 121.73 Million EUR | 0.75% |
| 2010 | 120.83 Million EUR | 5.67% |
| 2009 | 114.34 Million EUR | 3.34% |
| 2008 | 110.64 Million EUR | 34.86% |
| 2007 | 82.04 Million EUR | 18.8% |
| 2006 | 69.06 Million EUR | 25.46% |
| 2005 | 55.04 Million EUR | 24.18% |
| 2004 | 44.32 Million EUR | -36.8% |
| 2003 | 70.14 Million EUR | 56.0% |
| 2002 | 44.96 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 43.99 Million EUR | 4.16% |
| 2024 Q1 | 42.23 Million EUR | 232.0% |
| 2023 Q4 | 12.72 Million EUR | -70.63% |
| 2023 Q3 | 43.31 Million EUR | 37.01% |
| 2023 Q2 | 31.61 Million EUR | -19.41% |
| 2023 FY | 127.64 Million EUR | 23.14% |
| 2023 Q1 | 39.22 Million EUR | 283.58% |
| 2022 Q3 | 33.5 Million EUR | 32.43% |
| 2022 FY | 103.65 Million EUR | -24.26% |
| 2022 Q2 | 25.29 Million EUR | -22.53% |
| 2022 Q1 | 32.65 Million EUR | 53.75% |
| 2022 Q4 | 10.22 Million EUR | -69.48% |
| 2021 Q4 | 21.24 Million EUR | -62.08% |
| 2021 FY | 136.85 Million EUR | 17.56% |
| 2021 Q1 | 27.34 Million EUR | -25.7% |
| 2021 Q2 | 35.4 Million EUR | 29.46% |
| 2021 Q3 | 56 Million EUR | 58.21% |
| 2020 Q1 | 12.03 Million EUR | -89.93% |
| 2020 Q2 | 13.01 Million EUR | 8.16% |
| 2020 Q3 | 53.56 Million EUR | 311.46% |
| 2020 FY | 116.4 Million EUR | -32.4% |
| 2020 Q4 | 36.8 Million EUR | -31.28% |
| 2019 Q3 | 52.78 Million EUR | 28.91% |
| 2019 Q2 | 40.94 Million EUR | -10.42% |
| 2019 Q1 | 45.71 Million EUR | 29.31% |
| 2019 FY | 172.2 Million EUR | 1.96% |
| 2019 Q4 | 119.53 Million EUR | 126.46% |
| 2018 Q1 | 41.43 Million EUR | 35.68% |
| 2018 FY | 168.88 Million EUR | 0.75% |
| 2018 Q2 | 37.38 Million EUR | -9.76% |
| 2018 Q3 | 54 Million EUR | 44.47% |
| 2018 Q4 | 35.35 Million EUR | -34.55% |
| 2017 Q2 | 42.37 Million EUR | 3.94% |
| 2017 Q3 | 51.15 Million EUR | 20.7% |
| 2017 Q4 | 30.53 Million EUR | -40.31% |
| 2017 Q1 | 40.77 Million EUR | 6.77% |
| 2017 FY | 167.62 Million EUR | 0.79% |
| 2016 Q4 | 38.18 Million EUR | -20.2% |
| 2016 Q3 | 47.85 Million EUR | 10.9% |
| 2016 Q2 | 43.14 Million EUR | 16.9% |
| 2016 Q1 | 36.91 Million EUR | 11.79% |
| 2016 FY | 166.3 Million EUR | 0.47% |
| 2015 Q2 | 36.9 Million EUR | -15.13% |
| 2015 Q4 | 33.01 Million EUR | -37.82% |
| 2015 Q3 | 53.1 Million EUR | 43.9% |
| 2015 FY | 165.53 Million EUR | 5.22% |
| 2015 Q1 | 43.47 Million EUR | 22.62% |
| 2014 Q2 | 33.71 Million EUR | -17.57% |
| 2014 Q3 | 49.19 Million EUR | 45.91% |
| 2014 Q4 | 35.45 Million EUR | -27.93% |
| 2014 FY | 157.31 Million EUR | 13.98% |
| 2014 Q1 | 40.9 Million EUR | 25.86% |
| 2013 Q3 | 41.62 Million EUR | 32.33% |
| 2013 Q1 | 32.74 Million EUR | 18.61% |
| 2013 FY | 138.02 Million EUR | 9.23% |
| 2013 Q4 | 32.5 Million EUR | -21.91% |
| 2013 Q2 | 31.45 Million EUR | -3.95% |
| 2012 FY | 126.36 Million EUR | 3.8% |
| 2012 Q1 | 32.73 Million EUR | 33.88% |
| 2012 Q2 | 29.51 Million EUR | -9.83% |
| 2012 Q3 | 37.57 Million EUR | 27.29% |
| 2012 Q4 | 27.6 Million EUR | -26.53% |
| 2011 Q3 | 37.45 Million EUR | 24.02% |
| 2011 Q2 | 30.2 Million EUR | -1.77% |
| 2011 Q1 | 30.74 Million EUR | 6.63% |
| 2011 FY | 121.73 Million EUR | 0.75% |
| 2011 Q4 | 24.45 Million EUR | -34.72% |
| 2010 FY | 120.83 Million EUR | 5.67% |
| 2010 Q4 | 28.83 Million EUR | -17.54% |
| 2010 Q3 | 34.97 Million EUR | 21.15% |
| 2010 Q2 | 28.86 Million EUR | 12.13% |
| 2010 Q1 | 25.74 Million EUR | -15.18% |
| 2009 Q1 | 22.87 Million EUR | 0.0% |
| 2009 Q2 | 26.68 Million EUR | 16.66% |
| 2009 Q4 | 30.35 Million EUR | -2.67% |
| 2009 FY | 114.34 Million EUR | 3.34% |
| 2009 Q3 | 31.18 Million EUR | 16.87% |
| 2008 FY | 110.64 Million EUR | 34.86% |
| 2007 FY | 82.04 Million EUR | 18.8% |
| 2006 FY | 69.06 Million EUR | 25.46% |
| 2005 FY | 55.04 Million EUR | 24.18% |
| 2004 FY | 44.32 Million EUR | -36.8% |
| 2003 FY | 70.14 Million EUR | 56.0% |
| 2002 FY | 44.96 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 151.84 Million EUR | 15.936% |
| Carl Zeiss Meditec AG | 290.39 Million EUR | 56.045% |
| Gerresheimer AG | 116.12 Million EUR | -9.919% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 37.795% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 37.795% |